The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation

NCT02793934 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2018-04-26

No results posted yet for this study

Summary

The Programme is focused on adult patients of any gender and age more than 18 y.o., with the next conditions:

1. Acute cerebrovascular events (ACE, ischemic stroke or intracerebral hemorrhage - specialty neurology)
2. Acute myocardial infarction (AMI, specialty cardiology)
3. Patients after total hip replacement (THR, specialty orthopaedia) The program is performed in the in-patient and out-patient rehabilitation departments in 13 regions of the Russian Federation (total 244 departments).

Conditions

  • Stroke
  • AMI
  • Total Hip Replacement

Interventions

OTHER

Scales

For stroke patients there are used scales: Modified Rankin Scale, NIH Stroke Scale , Glasgow Coma Scale, Dysphagia Severity, Rating Scale Speech or Language Impairment Severity Rating Scale, Modified Rivermead Mobility Index, Berg Balance Scale, Modified Ashworth Scale, Medical Research Council Scale, Frenchay Arm Test, Montreal Cognitive Assessment Scale, Spielberger Scale, Beck's Depression Inventory, Visual Analogue Scale, Functional Independence Measure For patients after AMI: Rankin scale, GRACE scale, MoCA, VAS, Hospital scale of anxiety and depression, Canadian classification if stenocardia For patients after THR: The pain of the operated joint on VAS scores The Harris scale (the total amount), Scale Lequesne (total), Hospital scale of anxiety

OTHER

New model of rehabilitation

OTHER

Old model of rehabilitation

OTHER

ICF reader

Sponsors & Collaborators

  • Ministry of Health, Russian Federation

    collaborator OTHER_GOV
  • Pirogov Russian National Research Medical University

    collaborator OTHER
  • Voino-Yasenetsky Krasnoyarsk State Medical University

    collaborator OTHER
  • Vladivostok State Medical University

    collaborator UNKNOWN
  • Ural district Institute of Brain

    collaborator UNKNOWN
  • Nizhegorodskoye Federal State Unitary Enterprise

    collaborator UNKNOWN
  • St. Petersburg State Pavlov Medical University

    lead OTHER

Principal Investigators

  • Shmonin Alexey, PhD · St. Petersburg State Pavlov Medical University

  • Shamalov Nikolay, Professor · Pirogov Russian National Medical Research University

  • Suvorov Andrey, PhD · Pirogov Russian National Medical Research University

  • Buylova Tatiana, Professor · Rehabilitation Center of Federal State Unitary Enterprise Nizhegorodskoye PROP

  • Tsykunov Mikhail, Professor · Central Research Institute of Traumatology and Orthopedics . Priorov Russian Ministry of Health

  • Belyaev Anatoliy, Professor · Vladivostok State Medical University

  • Prokopenko Sergei, Professor · Krasnoyarsk State Medical University named after Prof. V.F.Voino-Yasenetsky

  • Khasanova Dina, Professor · Kazan State Medical University Russian Ministry of Health

  • Bodrova Rezeda, PhD · Kazan State Medical Academy

  • Aronov David, Professor · State Research Center for Preventive Medicine Health Ministry of Russia

  • Bubnova Marina, Professor · State Research Center for Preventive Medicine Health Ministry of Russia

  • Belkin Anatoliy, Professor · Ural State Medical University Russian Ministry of Health

  • Mishina Irina, Professor · Ivanovo State Medical Academy Russian Ministry of Health

  • Sarana Andrey, PhD · Saint-Petersburg City Hospital № 40 of Recreation Area

  • Ivanova Natalya, Professor · Russian Research Neurosurgical Polenovs Institute

  • Yashkov Alexander, Professor · Samara State Medical University

  • Maltseva Mariya, Professor · St. Petersburg State Pavlov Medical University

  • Soloveva Liudmila, MD · St. Petersburg State Pavlov Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2020-09-30
Completion
2020-12-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02793934 on ClinicalTrials.gov